Advances on the tear osmolarity of mechanism and clinical application in dry eye

doi:10.3877/cma.j.issn.2095-2007.2021.05.009

Abstract

Abstract:

The increase of tear osmolarity is the core mechanism in the development of dry eye. As an objectively measurable indicator for the diagnosis and monitoring of dry eye, tear osmolarity has been widely used in clinic. It has been demonstrated that the tear osmolarity linked with dry eye, and has been used widely in clinical diagnosis and other aspects for dry eye. The research progress of tear osmolarity of mechanism and clinical application in dry eye were reviewed in this article.

Key words: Tear film, Tear osmolarity, Dry eye

Jingyi Wang, Ying Jie. Advances on the tear osmolarity of mechanism and clinical application in dry eye[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2021, 11(05): 301-305.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhykyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2007.2021.05.009

https://zhykyxzz.cma-cmc.com.cn/EN/Y2021/V11/I05/301

Figures/Tables 2

References 54

[1]	亚洲干眼协会中国分会，海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组，中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识：检查和诊断(2020年)[J]. 中华眼科杂志，2020，56(10)：741-747.
[2]	接英，李思源. 重视干眼的规范化诊疗[J]. 眼科，2019，28(6)：401-403.
[3]	Nelson JD, Craig JP, Akpek EK, et al. TFOS DEWS Ⅱ introduction[J]. Ocular Surface, 2017, 15(3): 269-275.
[4]	Stahl U, Willcox M, Stapleton F. Osmolality and tear film dynamics[J]. Clinical & Experimental Optometry, 2012, 95(1): 3-11.
[5]	Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease[J]. Am J Ophthalmol, 2011, 151(5): 792-798.
[6]	Amparo F, Jin Y, Hamrah P, et al. What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease？[J]. Am J Ophthalmol, 2014, 157(1): 69-77.
[7]	Julio G, Lluch S, Pujol P, et al. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye[J]. Ophthalmic Physiol Opt, 2012, 32(4): 317-323.
[8]	Galvez A, Morales MP, Eltit JM, et al. A rapid and strong apoptotic process is triggered by hyperosmotic stress in cultured rat cardiac myocytes[J]. Cell Tissue Res, 2001, 304(2): 279-285.
[9]	Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting[J]. Ocul Surf, 2013, 11(4): 246-258.
[10]	Lechner SG, Markworth S, Poole K, et al. The molecular and cellular identity of peripheral osmoreceptors[J]. Neuron, 2011, 69(2): 332-344.
[11]	Clouzeau C, Godefroy D, Riancho L, et al. Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro[J]. Mol Vis, 2012, 18: 851-863.
[12]	Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways[J]. Cornea, 2007, 26(4): 452-460.
[13]	Luo L, Li DQ, Corrales RM, et al. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface[J]. Eye Contact Lens, 2005, 31(5): 186-193.
[14]	Lam H, Bleiden L, Paiva CSD, et al. Tear cytokine profiles in dysfunctional tear syndrome[J]. Am J Ophthalmol, 2009, 147(2): 198-205.
[15]	Charles JD, Zeng W, Yi WC, et al. Tear interferon-gamma as a biomarker for evaporative dry eye disease[J]. Invest Ophth Vis Sci, 2016, 57(11): 4824-4830.
[16]	Kook KY, Jin R, Li L, et al. Tear osmolarity and matrix metallopeptidase-9 in dry eye associated with Sjgren′s syndrome[J]. Korean Journal of Ophthalmology, 2020, 34(3): 179-186.
[17]	Pflugfelder SC, Paiva CSD. The pathophysiology of dry eye disease: what we know and future directions for research[J]. Ophthalmology, 2017, 124(11): S4-S13.
[18]	Serdar A, Fatih T. Evaluation of tear osmolarity and tear function in patients with Behet′s syndrome[J]. Can J Ophthalmol, 2018, 54(2): 176-179.
[19]	Joossen C, Baán A, Moreno-Cinos C, et al. A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation[J]. Sci Rep, 2020, 10(1): 17268.
[20]	Mirinae K, Seung KH, Kyung-Sun N. Correlation between tear osmolarity and other ocular surface parameters in primary Sjgren′s syndrome[J]. Korean J Ophthalmol, 2017, 31(1): 25-31.
[21]	Ng ALK, Choy BNK, Chan TCY, et al. Comparison of tear osmolarity in rheumatoid arthritis patients with and without secondary Sjogren syndrome[J]. Cornea, 2017, 36(7): 805-809.
[22]	Miserocchi E, Iuliano L, Berchicci L, et al. Tear film osmolarity in ocular mucous membrane pemphigoid[J]. Cornea, 2014, 33(7): 668-672.
[23]	Türkylmaz K, Türkylmaz AK, Kurt A, et al. Investigation of tear osmolarity in early rheumatoid arthritis: relation to disease activity[J]. Can J Ophthalmol, 2013, 48(4): 235-239.
[24]	Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease[J]. Ophthalmology, 2017, 124(11): S20-S26.
[25]	Xiao JX, Muhammed YA, Chen X, et al. Functional and morphological evaluation of meibomian glands in the assessment of meibomian gland dysfunction subtype and severity[J]. Am J Ophthalmol, 2020, 209: 160-167.
[26]	Akpek EK, Wu HY, Karakus S, et al. Differential diagnosis of Sjgren versus non-Sjgren dry eye through tear film biomarkers[J]. Cornea, 2020, 39(8): 991-997.
[27]	洪晶. 密切关注眼表黏蛋白研究及其在干眼诊疗中的意义[J]. 中华实验眼科杂志，2020，38(11)：910-915.
[28]	Wylgaa A, Sdziak-Marcinek B, Pilch J, et al. Alteration of blinking and sex differences during physical exercise affect tear osmolarity[J]. J Hum Kinet, 2019, 67: 143-151.
[29]	Jie Y, Sella R, Feng J, et al. Evaluation of incomplete blinking as a measurement of dry eye disease[J]. The Ocular Surface, 2019, 17(3): 440-446.
[30]	Talens-Estarelles C, García-Marqués JV, Cervino A, et al. Use of digital displays and ocular surface alterations: A review[J]. The Ocular Surface, 2020, 19: 252-265.
[31]	Hu JW, Zhu XP, Pan SY, et al. Prevalence and risk factors of dry eye disease in young and middle-aged office employee: a Xi′an Study[J]. Int J Ophthalmol, 2021, 14(4): 567-573.
[32]	Yazici A, Sari ES, Sahin G, et al. Change in tear film characteristics in visual display terminal users[J]. Eur J Ophthalmol, 2015, 25(2): 85-89.
[33]	Montani G, Martino M. Tear film characteristics during wear of daily disposable contact lenses[J]. Clin Ophthalmol, 2020, 14: 1521-1531.
[34]	Ramamoorthy P, Khanal S, Nichols J. Inflammatory proteins associated with contact lens-related dry eye[J]. Cont Lens Anterior Eye, 2021: 101442.
[35]	Melhusseiny A, Akhalil A, Sheikh RH, et al. New approaches for diagnosis of dry eye disease[J]. Int J Ophthalmol, 2019, 12(10): 1618-1628.
[36]	Tomlinson A, Mccann LC, Pearce EI. Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques[J]. Cornea, 2010, 29(9): 1036-1041.
[37]	Pensyl CD, Benjamin WJ. Vapor pressure osmometry: minimum sample microvolumes[J]. Acta Ophthalmologica Scandinavica, 2009, 77(1): 27-30.
[38]	潘士印，肖湘华，王养正，等. 泪液渗透压与干眼[J]. 中华眼科杂志，2011，47(5)：475-477.
[39]	Fagehi R. Development in tear film osmolarity assessments: a review[J]. Nepal J Ophthalmol, 2021, 13(25): 122-132.
[40]	Cartes C, López D, Salinas D, et al. Dry eye is matched by increased intrasubject variability in tear osmolarity as confirmed by machine learning approach[J]. Archivos de la Sociedad Espaola de Oftalmología, 2019, 94(7): 337-342.
[41]	Park J, Choi Y, Han G, et al. Evaluation of tear osmolarity measured by I-Pen osmolarity system in patients with dry eye[J]. Sci Rep, 2021, 11(1): 7726.
[42]	Shimazaki J, Sakata M, Den S, et al. Tear film osmolarity measurement in Japanese dry eye patients using a handheld osmolarity system[J]. Diagnostics, 2020, 10(10): 789.
[43]	König S, Priglinger S, Schaumberger M, et al. Tear film osmolarity in normal individuals: comparison of two osmometers[J]. Klin Monbl Augenheilkd, 2020, 237(5): 649-654.
[44]	Alan T, Santosh K, Kanna R, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis[J]. Invest Ophthalmol Vis Sci, 2006, 47(10): 4309.
[45]	Sullivan BD, Diane W, Nichols KK, et al. An objective approach to dry eye disease severity[J]. Invest Ophthalmol Vis, 2010, 51(12): 6125-6130.
[46]	Wang MTM, Ormonde SE, Muntz A, et al. Diagnostic profile of tear osmolarity and inter-ocular variability for dry eye disease[J]. Clin Exp Ophthalmol, 2020, 48(2): 255-257.
[47]	Sullivan BD. Variability of tear osmolarity measurements with a point-of-care system in healthy subjects-systematic review[J]. Cornea, 2019, 38(6): e21-e23.
[48]	Setten GBV. Osmokinetics: defining the characteristics of osmotic challenge to the ocular surface[J]. Klinische Monatsbltter für Augenheilkunde, 2020, 237(5): 644-648.
[49]	Tashbayev B, Utheim TP, Utheim YA, et al. Utility of tear osmolarity measurement in diagnosis of dry eye disease[J]. Sci Rep, 2020, 10(1): 5542.
[50]	Ozulken K, Aydemir GA, Tekin K, et al. Correlation of non-invasive tear break-up time with tear osmolarity and other invasive tear function tests[J]. Semin Ophthalmol, 2020, 35(1): 78-85.
[51]	Suzuki M, Massingale ML, Ye F, et al. Tear osmolarity as a biomarker for dry eye disease severity[J]. Invest Ophthalmol Vis Sci, 2010, 51(9): 4557-4561.
[52]	Utine CA, Bçakçgil M, Yavuz S, et al. Tear osmolarity measurements in dry eye related to primary Sjögren′s syndrome[J]. Curr Eye Res, 2011, 36(8): 683-690.
[53]	Pena-Verdeal H, García-Resúa C, Vazquez-Sanchez C, et al. Inter-eye osmolarity differences in patients with symptomatic and non-symptomatic dry eyes[J]. Arquivos Brasileiros de Oftalmologia, 2020, 83(2): 103-108.
[54]	Bunya VY, Fuerst NM, Pistilli M, et al. Variability of tear osmolarity in patients with dry eye[J]. JAMA Ophthalmol, 2015, 133(6): 662-667.

干眼类型	所得结论	参考文献
水液缺乏型干眼	干燥综合征患者泪液渗透压平均值为(311.1±16.4)mOsm/L	[20]
	干燥综合征患者的泪液渗透压与疾病活动性相关性较强	[21]
	所需样本量小；检测时间短；原位测量避免泪液转移	[22]
	类风湿性关节炎患者泪液渗透压普遍高于正常值，且与类风湿性关节炎活动评分呈正相关	[23]
脂质异常型干眼	睑板腺出现损伤或阻塞时患者泪液渗透压明显高于正常人群	[24]
	将患者按睑板腺分泌能力分组，睑板腺低分泌组和睑板腺阻塞组患者的泪液渗透压超过308 mOsm/L	[25]
黏蛋白异常型干眼	干燥综合征患者泪液中的黏蛋白5AC含量降低，且与泪液渗透压值相关	[26]
泪液动力学异常型干眼	瞬目频率下降越多，泪液渗透压越高	[28]
混合型干眼	职业计算机使用者平均泪液渗透压明显高于未使用者，且增长值与计算机使用时间存在一定相关性	[32]
	配戴角膜接触镜患者的泪液渗透压和白介素-8、白介素-13及白介素-15等炎症因子的含量明显高于未配戴者	[34]

干眼类型	所得结论	参考文献
水液缺乏型干眼	干燥综合征患者泪液渗透压平均值为(311.1±16.4)mOsm/L	[20]
	干燥综合征患者的泪液渗透压与疾病活动性相关性较强	[21]
	所需样本量小；检测时间短；原位测量避免泪液转移	[22]
	类风湿性关节炎患者泪液渗透压普遍高于正常值，且与类风湿性关节炎活动评分呈正相关	[23]
脂质异常型干眼	睑板腺出现损伤或阻塞时患者泪液渗透压明显高于正常人群	[24]
	将患者按睑板腺分泌能力分组，睑板腺低分泌组和睑板腺阻塞组患者的泪液渗透压超过308 mOsm/L	[25]
黏蛋白异常型干眼	干燥综合征患者泪液中的黏蛋白5AC含量降低，且与泪液渗透压值相关	[26]
泪液动力学异常型干眼	瞬目频率下降越多，泪液渗透压越高	[28]
混合型干眼	职业计算机使用者平均泪液渗透压明显高于未使用者，且增长值与计算机使用时间存在一定相关性	[32]
	配戴角膜接触镜患者的泪液渗透压和白介素-8、白介素-13及白介素-15等炎症因子的含量明显高于未配戴者	[34]

测量方法	原理	优点	缺点
凝固点降低法	溶液的凝固点随溶质浓度增加而降低	所需样本量小；检测时间短	操作费时；转移泪液过程存在泪液蒸发的问题；需主观判断融化时刻
蒸汽压法	溶液的蒸汽压随溶质浓度增加而降低	准确度高；检测时间短	所需样本量大；转移泪液过程中泪液有蒸发
电阻抗法	溶液的电阻随溶质浓度增加而降低	所需样本量小；检测时间短；原位测量避免泪液转移	价格昂贵

测量方法	原理	优点	缺点
凝固点降低法	溶液的凝固点随溶质浓度增加而降低	所需样本量小；检测时间短	操作费时；转移泪液过程存在泪液蒸发的问题；需主观判断融化时刻
蒸汽压法	溶液的蒸汽压随溶质浓度增加而降低	准确度高；检测时间短	所需样本量大；转移泪液过程中泪液有蒸发
电阻抗法	溶液的电阻随溶质浓度增加而降低	所需样本量小；检测时间短；原位测量避免泪液转移	价格昂贵

Please choose a citation manager

Content to export